See What HealthDay Can Do For You
Contact Us

FDA: J&J Contaminated COVID-19 Vaccine Doses Must Be Discarded

Plant responsible for contamination has been closed for two months; the FDA has not yet decided whether it can reopen

glass bottles of vaccine liquid with pink and blue caps

FRIDAY, June 11, 2021 (HealthDay News) -- About 60 million doses of the Johnson & Johnson COVID-19 vaccine must be discarded due to possible contamination, the U.S. Food and Drug Administration has decided.

It will allow about 10 million doses to be distributed in the United States or shipped to other countries, but with a warning, according to people familiar with the situation, The New York Times reported.

More than 100 million doses of Johnson & Johnson and at least 70 million doses of AstraZeneca made at Emergent BioSolutions in Baltimore were put on hold in March after workers contaminated a batch of the Johnson & Johnson vaccine with a key ingredient used to produce the AstraZeneca vaccine.

The Emergent factory has been closed for two months and the FDA has not yet decided whether it can reopen, those with knowledge of the situation told The Times.

The New York Times Article

Physician's Briefing